Financhill
Back

Altamira Therapeutics Quote, Financials, Valuation and Earnings

Altamira Therapeutics Price Quote

$0.44
+0.00 (+0.57%)
(Updated: November 22, 2024 at 5:55 PM ET)

Altamira Therapeutics Key Stats

Sell
13
Altamira Therapeutics (CYTO) is a Sell

Day range:
$0.41 - $0.45
52-week range:
$0.40 - $17.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.26%

Volume:
24K
Avg. volume:
88.2K
1-year change:
-94.06%
Market cap:
$1.7M
Revenue:
$188.4K
EPS:
$0.48

How Much Does Altamira Therapeutics Make?

Data Unavailable

Is Altamira Therapeutics Growing As A Company?

Data Unavailable

Altamira Therapeutics Stock Price Performance

What Is Altamira Therapeutics 52-Week High & Low?

Altamira Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Altamira Therapeutics?

Is Altamira Therapeutics Cash Flow Positive?

Data Unavailable

Altamira Therapeutics Return On Invested Capital

Data Unavailable

Altamira Therapeutics Earnings Date & Stock Price

Altamira Therapeutics Competitors

Altamira Therapeutics Dividend Yield

Altamira Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.35
Upside from Last Price: 1122.64%

Major Shareholders

  • How many CYTO shares are owned by institutional investors?
    122.1K CYTO shares are owned by institutional investors
  • How many CYTO shares are owned by insiders?
    0 CYTO shares are owned by insiders